Dr. Martin Roessle

Dr. Martin Roessle is a Gastroenterologist/Hepatologist with an impressive career spanning over four decades. He received his MD from the University of Freiburg in 1974 and completed his specialist medical training in Gastroenterology and Hepatology at the Medical University Clinic Freiburg. He also pursued a Fellowship for experimental work on hepatic encephalopathy at the National Institute of Health, Bethesda, United States, from 1985 to 1986.

Currently, Dr. Roessle holds several positions, including Head Senior Physician at the University Hospital Freiburg and a consultant at Saarbrücken Clinic, and owns a private practice in Gastroenterology and Hepatology in Freiburg, Germany. Dr. Roessle is affiliated with several professional organizations, such as the German Society for Digestive and Metabolic Diseases (DGVS), the German Society for the Study of the Liver (GASL), and the German Society for Ultrasound in Medicine (DEGUM).

Dr. Roessle has made significant contributions to the field of Gastroenterology and Hepatology. He is known for his scientific work and has published over 200 scientific papers. Additionally, he has been the spokesperson of the steering committee of the TIPS registry since 2004, and he initiated, developed, and implemented the transjugular intrahepatic portosystemic shunt (TIPS), a new interventional therapy for portal hypertension.

Dr. Roessle's clinical focus includes viral hepatitis B and C, chronic inflammatory bowel disease, portal hypertension, TIPS, ultrasound diagnostics (instructor status of DEGUM), and endoscopy. He received several awards in recognition of his work, including the European Association for the Study of the Liver Innovation Award in 2022, the Lucie-Bolte Price in 2019, and the Gödecke Research Price in 1985.